BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 17159010)

  • 1. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
    Rothenbacher D; Koenig W; Brenner H
    Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
    Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR
    J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.
    Tang WH; Steinhubl SR; Van Lente F; Brennan D; McErlean E; Maroo A; Francis GS; Topol EJ
    Am Heart J; 2007 Jan; 153(1):36-41. PubMed ID: 17174634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
    Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
    Circulation; 2005 Jul; 112(1):110-6. PubMed ID: 15983245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
    N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study.
    Schnabel R; Rupprecht HJ; Lackner KJ; Lubos E; Bickel C; Meyer J; Münzel T; Cambien F; Tiret L; Blankenberg S;
    Eur Heart J; 2005 Feb; 26(3):241-9. PubMed ID: 15618051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    J Hypertens; 2008 Jan; 26(1):26-34. PubMed ID: 18090537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
    West MJ; Nestel PJ; Kirby AC; Schnabel R; Sullivan D; Simes RJ; Pollicino C; Lubos E; Münzel TF; White HD; Tonkin AM; Bickel C; Tiret L; Blankenberg S;
    Eur Heart J; 2008 Apr; 29(7):923-31. PubMed ID: 18296678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease.
    Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
    Arch Neurol; 2006 Jan; 63(1):60-5. PubMed ID: 16286536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of NT-proBNP in early risk stratification of acute coronary syndromes.
    Almeida R; Mariano L; Gavina C; Pinho T; Vasconcelos M; Ferreira A; Maciel MJ; Gonçalves FR
    Rev Port Cardiol; 2006 Jan; 25(1):71-5. PubMed ID: 16623357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization.
    Sir JJ; Chung WY; Hwang SJ; Kang HJ; Cho YS; Koo BK; Chae IH; Choi DJ; Kim HS; Sohn DW; Kim CH; Oh BH; Park YB; Choi YS
    Int J Cardiol; 2008 Jun; 126(3):322-32. PubMed ID: 17544525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Admission NT-proBNP levels, renal insufficiency and age as predictors of mortality in elderly patients hospitalized for acute dyspnea.
    Reny JL; Millot O; Vanderecamer T; Vergnes C; Barazer I; Sedighian S; Berdagué P
    Eur J Intern Med; 2009 Jan; 20(1):14-9. PubMed ID: 19237086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
    Harutyunyan MJ; Mathiasen AB; Winkel P; Gøtze JP; Hansen JF; Hildebrandt P; Jensen GB; Hilden J; Jespersen CM; Kjøller E; Kolmos HJ; Gluud C; Kastrup J;
    Scand J Clin Lab Invest; 2011 Feb; 71(1):52-62. PubMed ID: 21108561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.